GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dimerix Ltd (OTCPK:SBMJF) » Definitions » Interest Expense (Positive)

SBMJF (Dimerix) Interest Expense (Positive)


View and export this data going back to 2004. Start your Free Trial

What is Dimerix Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.


Dimerix Business Description

Industry
Traded in Other Exchanges
Address
425 Smith Street, Fitzroy, VIC, AUS, 3065
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.